Skyrizi 180 MG/1.2 ML on-body 1.2ML
Ended Awarded
- Contract number
- SPE2DR26FT372
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of SKYRIZI 180 mg/1.2 mL on-body injectors. This is a firm fixed-price, non-set-aside contract with a completion date of November 19, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 master vehicle that runs through December 2026 and serves as the company's primary mechanism for supplying pharmaceuticals and medical commodities to military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive portfolio of medications, vaccines, and medical devices across multiple therapeutic categories to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract awards are consistently competitively awarded and demonstrate its capability to meet federal procurement requirements across a wide range of medical products, from specialty medications to generic pharmaceuticals. SKYRIZI is an immunosuppressive biologic used for inflammatory skin conditions and has become part of AmerisourceBergen's expanding portfolio of specialty pharmaceutical deliveries to support military medical readiness.
Quick answers
Who was awarded contract SPE2DR26FT372?
SPE2DR26FT372 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FT372 worth?
The government has obligated $12,467 on SPE2DR26FT372.
Is contract SPE2DR26FT372 an order under another contract?
Yes. SPE2DR26FT372 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT372 competed?
The extent of competition for SPE2DR26FT372 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award